Skip to main content
×
×
Home

Effectiveness of Lactobacillus helveticus and Lactobacillus rhamnosus for the management of antibiotic-associated diarrhoea in healthy adults: a randomised, double-blind, placebo-controlled trial

  • Malkanthi Evans (a1), Ryan P. Salewski (a1), Mary C. Christman (a2), Stephanie-Anne Girard (a3) and Thomas A. Tompkins (a3)...
Abstract

Broad-spectrum antibiotic use can disrupt the gastrointestinal microbiota resulting in diarrhoea. Probiotics may be beneficial in managing this type of diarrhoea. The aim of this 10-week randomised, double-blind, placebo-controlled, parallel study was to investigate the effect of Lactobacillus helveticus R0052 and Lactobacillus rhamnosus R0011 supplementation on antibiotic-associated diarrhoea in healthy adults. Subjects were randomised to receive 1 week of amoxicillin–clavulanic acid (875 mg/125 mg) once per day, plus a daily dose of 8×109 colony-forming units of a multi-strain probiotic (n 80) or placebo (n 80). The probiotic or placebo intervention was maintained for 1 week after completion of the antibiotic. Primary study outcomes of consistency and frequency of bowel movements were not significantly different between the probiotic and placebo groups. The secondary outcomes of diarrhoea-like defecations, Gastrointestinal Symptoms Rating Scale scores, safety parameters and adverse events were not significantly different between the probiotic intervention and the placebo. A post hoc analysis on the duration of diarrhoea-like defecations showed that probiotic intervention reduced the length of these events by 1 full day (probiotic, 2·70 (sem 0·36) d; placebo, 3·71 (sem 0·36) d; P=0·037; effect size=0·52). In conclusion, this study provides novel evidence that L. helveticus R0052 and L. rhamnosus R0011 supplementation significantly reduced the duration of diarrhoea-like defecations in healthy adults receiving antibiotics.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Effectiveness of Lactobacillus helveticus and Lactobacillus rhamnosus for the management of antibiotic-associated diarrhoea in healthy adults: a randomised, double-blind, placebo-controlled trial
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Effectiveness of Lactobacillus helveticus and Lactobacillus rhamnosus for the management of antibiotic-associated diarrhoea in healthy adults: a randomised, double-blind, placebo-controlled trial
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Effectiveness of Lactobacillus helveticus and Lactobacillus rhamnosus for the management of antibiotic-associated diarrhoea in healthy adults: a randomised, double-blind, placebo-controlled trial
      Available formats
      ×
Copyright
Corresponding author
* Corresponding author: Dr M. Evans, fax +1 519 438 8314, email mevans@kgksynergize.com
References
Hide All
1. Bartlett, JG (2002) Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 346, 334339.
2. Gilbert, D (1994) Aspects of the safety profile of oral antibacterial agents. Infect Dis Clin Pract 3, 236247.
3. Forssten, S, Evans, M, Wilson, D, et al. (2014) Influence of a probiotic mixture on antibiotic induced microbiota disturbances. World J Gastroenterol 20, 1187811885.
4. Dunne, C (2001) Adaptation of bacteria to the intestinal niche: probiotics and gut disorder. Inflamm Bowel Dis 7, 136145.
5. Hogenauer, C, Hammer, HF, Krejs, GJ, et al. (1998) Mechanisms and management of antibiotic-associated diarrhea. Clin Infect Dis 27, 702710.
6. Young, VB & Schmidt, TM (2004) Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota. J Clin Microbiol 42, 12031206.
7. White, AR, Stokes, DH, Slocombe, B, et al. (1985) Bactericidal effects of amoxycillin/clavulanic acid and ticarcillin/clavulanic acid in in-vitro kinetic models. J Antimicrob Chemother 15, Suppl. A, 227232.
8. Gillies, M, Ranakusuma, A, Hoffmann, T, et al. (2015) Common harms from amoxicillin: a systematic review and meta-analysis of randomized placebo-controlled trials for any indication. CMAJ 187, E21E31.
9. Engelbrektson, A, Korzenik, JR, Pittler, A, et al. (2009) Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy. J Med Microbiol 58, 663670.
10. Caron, F, Ducrotte, P, Lerebours, E, et al. (1991) Effects of amoxicillin-clavulanate combination on the motility of the small intestine in human beings. Antimicrob Agents Chemother 35, 10851088.
11. Coconnier, MH, Lievin, V, Bernet-Camard, MF, et al. (1997) Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB. Antimicrob Agents Chemother 41, 10461052.
12. Hudault, S, Lievin, V, Bernet-Camard, MF, et al. (1997) Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl Environ Microbiol 63, 513518.
13. Rodgers, B, Kirley, K & Mounsey, A (2013) PURLs: prescribing an antibiotic? Pair it with probiotics. J Fam Pract 62, 148150.
14. Goldenberg, JZ, Lytvyn, L, Steurich, J, et al. (2015) Probiotics for the prevention of pediatric antibiotic-associated diarrhea. The Cochrane Database of Systematic Reviews 2015 http://www.cochrane.org/CD004827/IBD_probiotics-prevention-antibiotic-associated-diarrhea-children
15. Hempel, S, Newberry, SJ, Maher, AR, et al. (2012) Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 307, 19591969.
16. Lewis, SJ & Heaton, KW (1997) Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 32, 920924.
17. Koning, CJ, Jonkers, DM, Stobberingh, EE, et al. (2008) The effect of a multispecies probiotic on the intestinal microbiota and bowel movements in healthy volunteers taking the antibiotic amoxycillin. Am J Gastroenterol 103, 178189.
18. McFarland, LV (1998) Epidemiology, risk factors and treatments for antibiotic-associated diarrhea. Dig Dis 16, 292307.
19. McFarland, LV (1993) Diarrhea acquired in the hospital. Gastroenterol Clin North Am 22, 563577.
20. McFarland, LV, Surawicz, CM, Greenberg, RN, et al. (1995) Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am J Gastroenterol 90, 439448.
21. Firmesse, O, Mogenet, A, Bresson, JL, et al. (2008) Lactobacillus rhamnosus R11 consumed in a food supplement survived human digestive transit without modifying microbiota equilibrium as assessed by real-time polymerase chain reaction. J Mol Microbiol Biotechnol 14, 9099.
22. Sherman, PM, Johnson-Henry, KC, Yeung, HP, et al. (2005) Probiotics reduce enterohemorrhagic Escherichia coli O157:H7-and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements. Infect Immun 73, 51835188.
23. Alemka, A, Clyne, M, Shanahan, F, et al. (2010) Probiotic colonization of the adherent mucus layer of HT29MTXE12 cells attenuates Campylobacter jejuni virulence properties. Infect Immun 78, 28122822.
24. Sadowska, B, Walencka, E, Wieckowska-Szakiel, M, et al. (2010) Bacteria competing with the adhesion and biofilm formation by Staphylococcus aureus . Folia Microbiol (Praha) 55, 497501.
25. Wine, E, Gareau, MG, Johnson-Henry, K, et al. (2009) Strain-specific probiotic (Lactobacillus helveticus) inhibition of Campylobacter jejuni invasion of human intestinal epithelial cells. FEMS Microbiol Lett 300, 146152.
26. Wallace, TD, Bradley, S, Buckley, ND, et al. (2003) Interactions of lactic acid bacteria with human intestinal epithelial cells: effects on cytokine production. J Food Prot 66, 466472.
27. Maydannik, V, Khaytovych, N, Boyarskaya, L, et al. (2010) Efficiency and safety of Lacidofil in children with antibiotic-associated diarrhoea caused by Clostridium difficile. Pediatr Obstet Gynecol 3, 5357.
28. Song, HJ, Kim, JY, Jung, SA, et al. (2010) Effect of probiotic Lactobacillus (Lacidofil(R) cap) for the prevention of antibiotic-associated diarrhea: a prospective, randomized, double-blind, multicenter study. J Korean Med Sci 25, 17841791.
29. Huang, JS, Bousvaros, A, Lee, JW, et al. (2002) Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci 47, 26252634.
30. Szajewska, H, Skorka, A & Dylag, M (2007) Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children. Aliment Pharmacol Ther 25, 257264.
31. Wright, K, Wright, H & Murray, M (2015) Probiotic treatment for the prevention of antibiotic-associated diarrhoea in geriatric patients: a multicentre randomised controlled pilot study. Australas J Ageing 34, 3842.
32. Hanifi, A, Culpepper, T, Mai, V, et al. (2015) Evaluation of Bacillus subtilis R0179 on gastrointestinal viability and general wellness: a randomised, double-blind, placebo-controlled trial in healthy adults. Benef Microbes 6, 1927.
33. Jones, ML, Martoni, CJ, Tamber, S, et al. (2012) Evaluation of safety and tolerance of microencapsulated Lactobacillus reuteri NCIMB 30242 in a yogurt formulation: a randomized, placebo-controlled, double-blind study. Food Chem Toxicol 50, 22162223.
34. Wind, RD, Tolboom, H, Klare, I, et al. (2010) Tolerance and safety of the potentially probiotic strain Lactobacillus rhamnosus PRSF-L477: a randomised, double-blind placebo-controlled trial in healthy volunteers. Br J Nutr 104, 18061816.
35. Kale-Pradhan, PB, Jassal, HK & Wilhelm, SM (2010) Role of Lactobacillus in the prevention of antibiotic-associated diarrhea: a meta-analysis. Pharmacotherapy 30, 119126.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed